AstraZeneca has joined other drugmakers in freezing prices in the United States for the rest of 2018, following criticism by U.S. President Donald Trump over the cost of medicine.
Roche on Thursday lifted its veil of secrecy over a patent that has reaped billions of dollars over the years but is due to expire on Dec. 18, depriving the Swiss drugmaker of a key source of income.
Henry Yeung, a pediatrician and president of the Hong Kong Doctors Union, has just boosted his orders for a popular vaccine for infants - stocking up in preparation for a surge in mainland Chinese visitors spooked by the country's latest vaccine scandal.
Shares of Eisai Co Ltd plunged as much as 21 percent after the results of its experimental Alzheimer's drug being developed with partner Biogen Inc failed to enthuse investors.
A U.S. Food and Drug Administration expert panel on Wednesday did not support approval of GlaxoSmithKline Plc's drug Nucala in treating a disease that limits airflow to the lungs.
(Reuters Health) - Chronic pain patients who take opioids may be less satisfied with their sex life and more likely to experience a lack of desire than people who don't rely on these prescription narcotics, a Danish study suggests.
A U.S. appeals court on Wednesday denied a request by Acorda Therapeutics Inc for a temporary court order blocking generic drug companies from launching lower-cost versions of its multiple sclerosis drug Ampyra.
Congo's health minister said on Wednesday that when its Ebola outbreak was first announced less than three months ago, he never dreamed it would be possible to contain it so swiftly.
Water buffaloes living in Iraq's southern wetland are in danger as low water levels and increased salinity are helping to spread disease among animals.
Objects allowing us to create disposable products from biomaterials using our household waste were among the most striking items on display at June's annual Royal College of Art (RCA) Graduate Exhibition Show. Jim Drury reports.
You might like...
Check out our Reuters News Now daily briefing for hand-picked stories from Reuters editors. It's all the news you need to start your day.
